Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone
暂无分享,去创建一个
[1] G. Jansen,et al. The first two patients with dura mater associated Creutzfeldt-Jakob disease in the Netherlands , 2001, Journal of Neurology.
[2] A. Hamad,et al. Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2001, Neurology.
[3] A. Hofman,et al. A Nationwide Cohort Study on Creutzfeldt-Jakob Disease among Human Growth Hormone Recipients , 2000, Neuroepidemiology.
[4] Y. Agid,et al. Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France , 1999, Neurology.
[5] Y. Agid,et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France , 1996, Neurology.
[6] J. Ironside,et al. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone]. , 1996, Nederlands tijdschrift voor geneeskunde.
[7] P. Blumbergs,et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. , 1990, Australian and New Zealand journal of medicine.
[8] R. Kalb,et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. , 1988, Journal of neurosurgery.
[9] B. Berg,et al. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. , 1985, The New England journal of medicine.
[10] D. Gajdusek,et al. DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.
[11] A. Devoe,et al. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.